MD analyst estimates
Pediatrix (MD) analyst ratings, the average price target and its range, and every firm's latest call.
MD analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Aug 19, 2026 | Jefferies | Jefferies Downgrades Pediatrix Medical Group (MD) to Hold | $28.00 |
| Aug 6, 2026 | UBS | Pediatrix Medical price target raised to $28 from $25 at UBS | $28.00 |
| Aug 5, 2026 | Deutsche Bank | Pediatrix Medical price target raised to $25 from $19 at Deutsche Bank | $25.00 |
| Jul 14, 2026 | Truist Financial | Pediatrix Medical price target raised to $28 from $23 at Truist | $28.00 |
| May 12, 2026 | UBS | Pediatrix Medical price target raised to $25 from $22 at UBS | $25.00 |
| May 8, 2026 | Mizuho Securities | Pediatrix Medical price target raised to $24 from $21 at Mizuho | $24.00 |
| Apr 20, 2026 | Jefferies | Pediatrix Medical price target raised to $27 from $24 at Jefferies | $27.00 |
| Feb 24, 2026 | UBS | Pediatrix Medical price target lowered to $22 from $23 at UBS | $22.00 |
| Feb 20, 2026 | Deutsche Bank | Pediatrix Medical price target lowered to $19 from $21 at Deutsche Bank | $19.00 |
| Feb 19, 2026 | Truist Financial | Pediatrix Medical price target lowered to $21 from $24 at Truist | $21.00 |
| Nov 10, 2025 | Truist Financial | Pediatrix Medical price target raised to $24 from $17 at Truist | $24.00 |
| Nov 5, 2025 | UBS | Pediatrix Medical price target raised to $23 from $16.50 at UBS | $23.00 |
| Oct 14, 2025 | Truist Financial | Pediatrix Medical price target raised to $17 from $16 at Truist | $17.00 |
| Oct 7, 2024 | Truist Financial | Pediatrix Medical price target raised to $13 from $10 at Truist | $13.00 |
| Sep 26, 2024 | Jefferies | Jefferies Upgrades Pediatrix Medical Group (MD) to Buy | $14.00 |
- 3 firms rate MD: 0 buy, 3 hold, 0 sell.
- The average price target is $26.60 from 5 analysts, from $24.00 to $28.00.
Updated 2026-11-02 17:50 UTC